I

Iterion Therapeutics

10 employees

Iterion Therapeutics is a venture-backed, clinical-stage biotechnology company that develops novel targeted cancer therapeutics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Pharmaceutical

Date founded

2014

Funding rounds raised

Total raised

$17M

from 8 investors over 8 rounds

I

Iterion Therapeutics raised $17M on February 16, 2021

Investors: Lumira Ventures, - and Viva BioInnovator

I

Iterion Therapeutics raised $2.6M on June 27, 2018

Investors: -, GOOSE Society of Texas, AngelMD and Cancer Prevention and Research Institute of Texas

I

Iterion Therapeutics raised $1M on July 6, 2015

Investors: -

FAQ